GET DAILY SIGNALSCelanese (CE) Delivers Q3 Earnings Beat and Raises Full-Year Outlook
Key Takeaways
- Celanese reported third quarter 2026 adjusted earnings per share (EPS) of $1.65, above the consensus estimate of roughly $1.55.
- Net sales reached $2,556 million, up 6% year over year, though slightly below the consensus estimate of about $2.62 billion.
- Management raised its full-year 2026 adjusted EPS outlook to approximately $6.00–$6.25 and lifted its free cash flow guidance to $750–$800 million.
- The Acetyl Chain segment drove results with net sales up 14%, while Engineered Materials sales slipped 1% on softer automotive demand and cost pressures.
- GAAP diluted EPS was $0.68, reflecting items excluded from the adjusted measure.
- Shares rose roughly 1.9% in after-hours trading following the release.
- For more context, visit the Major News, Today's Price Move, Price Targets, and Forecasts pages for Celanese (CE).
Why These Results Matter
Celanese (CE) is a global chemical and specialty materials company whose quarterly performance provides a useful window into industrial demand across sectors such as automotive, electronics, consumer goods, and construction. The third quarter is particularly relevant because it shows whether the company can maintain earnings momentum while also improving cash generation and reducing leverage. In the prior quarter, adjusted EBIT stood at $470 million, so the latest sequential trends highlight how well management is handling raw material inflation, logistics costs, and uneven end-market conditions. For investors, earnings quality, free cash flow, and balance sheet progress remain central to the investment thesis.
Breaking Down the Reported Numbers
Celanese (CE) delivered third quarter 2026 net sales of $2,556 million, a 6% increase from $2,419 million a year earlier, though this came in slightly below the consensus estimate of about $2.62 billion. Adjusted EPS reached $1.65, beating the analyst estimate of roughly $1.55 and improving from $1.34 in the year-ago quarter. GAAP diluted EPS from continuing operations was $0.68.
Segment performance showed clear divergence. The Acetyl Chain posted net sales of $1.21 billion, up 14% year over year, with adjusted EBIT of $236 million. Engineered Materials recorded net sales of $1.37 billion, down 1% year over year, with adjusted EBIT of $209 million; growth in medical and electronics applications was offset by weaker automotive volumes and higher costs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Cash flow stood out as a positive: operating cash flow reached $538 million and free cash flow came in at $461 million. Management raised its full-year 2026 adjusted EPS guidance to approximately $6.00–$6.25 and increased its free cash flow outlook to $750–$800 million.
Market Reaction and Sentiment
The initial market response was modestly positive, with Celanese (CE) shares rising about 1.9% in after-hours trading after the release. The adjusted EPS beat and the raised full-year outlook appeared to outweigh the modest revenue miss, indicating that investors focused on the company’s cash generation and deleveraging progress. The gap between adjusted EPS and the lower GAAP figure reflects items excluded from the adjusted measure, a detail worth monitoring. Sentiment stays measured, however, given ongoing softness in automotive demand and still-elevated leverage, which could sustain volatility in the shares.
Forward Outlook and Areas to Watch
Looking ahead, attention will center on whether Celanese (CE) can convert its raised guidance into sustained free cash flow and further debt reduction. The company expects to exit 2026 with net debt-to-operating EBITDA of roughly 4.7x, keeping balance sheet improvement a key theme. End-market demand is another focus, as automotive volumes have been uneven and raw material inflation plus higher logistics costs continue to pressure the Engineered Materials segment. Management is also preparing to commercialize three expansion projects in that business during the first half of 2027, which could influence the growth path. Finally, the Acetyl Chain’s ability to maintain pricing favorability and capture spot opportunities will matter for margin resilience. With divestiture proceeds moving toward longer-term targets, the pace of portfolio simplification may also shape how investors view earnings quality through the cycle.
Integrating AI Tools Into My Research Process
From what I see, combining traditional financial analysis with AI-driven screening helps surface comparable companies and monitor shifting conditions more efficiently. I often run quick checks with Tickeron’s AI Screener when evaluating names like Celanese (CE) to identify peers and spot potential opportunities across industries. This approach adds another layer of context without replacing fundamental review.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CE's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for CE moved out of overbought territory on October 29, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 instances where the indicator moved out of the overbought zone. In 18 of the 21 cases the stock moved lower in the days that followed. This puts the odds of a move down at 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
CE broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on CE as a result. In 69 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for CE just turned positive on October 15, 2026. Looking at past instances where CE's MACD turned positive, the stock continued to rise in 33 of 42 cases over the following month. The odds of a continued upward trend are 79%.
CE moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CE crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where CE advanced for three days, in 188 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 143 of 187 cases where CE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.298) is normal, around the industry mean (1.207). P/E Ratio (-4.616) is within average values for comparable stocks, (3.806). Projected Growth (PEG Ratio) (1.742) is also within normal values, averaging (3.769). Dividend Yield (0.002) settles around the average of (0.183) among similar stocks. P/S Ratio (0.530) is also within normal values, averaging (0.578).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a producer of industrial chemicals
Industry ChemicalsMajorDiversified
Advertisement